Shared on10 Aug 25Fair value Increased 11%
Viemed Healthcare’s consensus price target has increased to $13.00, reflecting improvements in profitability and valuation as evidenced by a higher net profit margin and a lower future P/E. What's in the News Raised 2025 net revenue guidance to $271–$277 million, up from $256–$265 million, driven by inclusion of Lehan's anticipated results.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 11%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 3.80%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Increased 7.40%
AnalystConsensusTarget has decreased future PE multiple from 25.4x to 22.8x.